Text Size

Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy Sample

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Randall Wolcott, Southwest Regional Wound Care Center
ClinicalTrials.gov Identifier:
NCT00882752
First received: September 29, 2008
Last updated: September 6, 2011
Last verified: September 2011
History of Changes
  Purpose

The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections. Therefore, this methodology may prove useful to other researchers or physicians.


Condition Intervention
Molecular Analysis
 Procedure: molecular analysis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Study Protocol: Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Southwest Regional Wound Care Center:

Primary Outcome Measures:
  • The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

colon biopsy


Enrollment: 1
Study Start Date: January 2008
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Ulcerative colitius
The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology.
 Procedure: molecular analysis
bowel disease

Detailed Description:

The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology. The molecular method worked well, so it is appropriate to share the method with the medical and scientific communities.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

People with ulcerative colitis.

Criteria

Inclusion Criteria:

  • Diagnosis of ulcerative colitis
  • Age >= 18 years old
  • Female

Exclusion Criteria:

Anyone not meeting inclusion criteria.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00882752

Sponsors and Collaborators
Southwest Regional Wound Care Center
Investigators
Principal Investigator: Randall Wolcott, MD Southwest Regional Wound Care
Principal Investigator: Randall Wolcott, MD Southwest Regional Wound Care Center
  More Information

No publications provided

Responsible Party: Randall Wolcott, Principal Investigator, Southwest Regional Wound Care Center
ClinicalTrials.gov Identifier: NCT00882752     History of Changes
Other Study ID Numbers: 56-RW-009
Study First Received: September 29, 2008
Last Updated: September 6, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Southwest Regional Wound Care Center:
Ulcerative Colitis (UC)

ClinicalTrials.gov processed this record on May 16, 2013